John Carey, MD
Dermatology · Albuquerque, NMNPI 1770578924
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 43.1% of the total. Reporting peaked in 2024 at $611 and has fallen 74.6% since, to $155 in 2025.
Across 119 payments — averaging $17.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$879
- Sun Pharmaceutical Industries Inc.$175
- Johnson & Johnson$156
- Revance Therapeutics, Inc.$153
- Incyte Corporation$153
- Lilly USA, LLC$115
- plus $409 from 13 others
What the payments were for
- Food & beverage$2,039100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 63 | $879 |
| Sun Pharmaceutical Industries Inc. | 8 | $175 |
| Johnson & Johnson | 9 | $156 |
| Revance Therapeutics, Inc. | 2 | $153 |
| Incyte Corporation | 7 | $153 |
| Lilly USA, LLC | 7 | $115 |
| Galderma Laboratories, L.p. | 7 | $101 |
| Novartis | 2 | $45 |
| Organon | 2 | $43 |
| Dermira, Inc. | 2 | $35 |
| Amgen | 1 | $31 |
| Pfizer | 2 | $29 |
| VYNE Pharmaceuticals Inc. | 1 | $23 |
| Sanofi | 1 | $20 |
| LEO Pharma Inc. | 1 | $19 |
| UCB, Inc. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $16 |
| Bristol Myers Squibb | 1 | $13 |
How this compares
$2,039 in reported general payments places this provider in the 60th percentile of 52 dermatology providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 58 | $3,258 |
| Mycophenolate Mofetil | 15 | $1,876 |
| Fluorouracil | 22 | $962 |
| ValacyclovirValacyclovir Hcl | 22 | $936 |
| Econazole Nitrate | 30 | $853 |
| Metronidazole | 16 | $846 |
| Doxycycline Hyclate | 24 | $635 |
| Gabapentin | 29 | $602 |
| Fluocinonide | 23 | $559 |
| Hydroxychloroquine Sulfate | 11 | $537 |
| Triamcinolone Acetonide | 28 | $441 |
| Imiquimod | 15 | $296 |
| Ketoconazole | 11 | $200 |
| Mupirocin | 12 | $132 |
| Minoxidil | 13 | $107 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Albuquerque
- John DurkinAlbuquerque$153K
- Barbara EinhornAlbuquerque$15K
- Carol PurcellAlbuquerque$9K
- Michaela JacobsAlbuquerque$7K
- Deeptej SinghAlbuquerque$5K
- Darren KemptonAlbuquerque$4K
- Catherine Tchanque-FossuoAlbuquerque$3K
- Shilpa ReddyAlbuquerque$3K
- Monica RomeroAlbuquerque$3K
- le Wen ChiuAlbuquerque$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.